Three-Month Follow-Up on Successful Treatment in a Cervical Cancer Patient with Chemoradiation Partial Response: A Case Report
Abstract
Introduction: The choice of therapy for cervical cancer strongly relies on the cancer stage. Stage IIB cervical cancer entails radiation therapy and chemotherapy, excluding surgery due to the risk of serious complications. This case is particularly interesting for discussion as the patient underwent a radical hysterectomy, bilateral salpingo-oophorectomy, and pelvic lymph node dissection following chemoradiation, resulting in a partial response.
Case Presentation: A 56-year-old woman presented with a complaint of continuous, progressive clear, and odorless fluid discharge from her birth canal, diagnosed with cervical cancer grade IIB. The patient underwent three cycles of cisplatin chemotherapy and radiation at a total dosage of 70.4 Gy over 38 sessions. Post-chemoradiation evaluation revealed a residual tumor with a diameter of 2 cm, and the patient underwent a radical hysterectomy, bilateral salpingooophorectomy, and pelvic lymph node dissection.
Conclusion: Surgery post-chemoradiation for cervical cancer in centers that don’t have any brachytherapy can be considered as an option, yielding positive effects with minimal side effects. Healthcare centers with limitations in brachytherapy can utilize EBRT boosters, which may be continued with surgery depending on the patient’s response to the earlier therapy.
Keywords
DOI: 10.33371/ijoc.v19i1.1202
Article Metrics
Abstract View: 460, 
PDF Download: 234
References
Fowler JR, Maani E V., Dunton CJ, Jack. BW. Cervical Cancer [Internet]. StatPearls. 2022 [cited 2023 Oct 7]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK431093/
Abu-Rustum NR, Yashar CM, Barber E, Bradley K, Brooks R, Campos SM, et al. Cervical Cancer. NCCN; 2023. p. 17–39.
Li F, Guo H, Qiu H, Liu S, Wang K, Yang C, et al. Urological Complications After Radical Hysterectomy with or without Radiotherapy for Cervical Cancer. Medicine (Baltimore). 2018;97(13):2–4.
Huang Y, Sanz J, Rodríguez N, Duran X, Martínez A, Li X, et al. Quantitative Assessments of Late Radiation-Induced Skin and Soft Tissue Toxicity and Correlation with RTOG Scales and Biological Equivalent Dose in Breast Cancer. Clin Transl Oncol. 2022;24(5):837–8.
Wahyuni FA, Supadmi W, Yuniarti E. Quality of Life in Cancer Outpatients Using the EORTC QLQ-C30 Questionnaire at PKU Muhammadiyah Yogyakarta Hospital. Farmasains. 2021;5(2):64–5.
Del Prete S, Caraglia M, Luce A, Montella L, Galizia G, Sperlongano P, et al. Clinical and pathological factors predictive of response to neoadjuvant chemotherapy in breast cancer: A single center experience. Oncol Lett. 2019;18(4):3873–9.
Boucher ANC, Ng O, Saunders JH, Acheson AG, Parsons SL. Anaemia and its effects on tumour regression grade and survival following chemotherapy in adenocarcinoma of the oesophagus. J Gastrointest Oncol. 2018;9(5):797–805.
National Comprehensive Cancer Network (NCCN). NCCN Guidlines for Patients: Cervical Cancer. 2023. p. 5–63.
Séka EN, Compaoré BG, Mossé BAW, Jaba S, N’chiépo KD, Benlemlih M, et al. Outcomes of External-Beam Radiation Therapy Boost with Conventional Fractionation in Cervical Cancer: A Retrospective Analysis about 133 Cases. J Cancer Ther. 2020;11(09):547–60.
Zhang J, Hsu H-C, Chen H-M, Wu S-Y. Contemporary External Beam Radiotherapy Boost or High Dose-Rate Brachytherapy Boost for Cervical Cancer: A Propensity-Score–Matched, Nationwide, Population-Based Cohort Study. Am J Cancer Res. 2021;11(4):1721–9.
Cibula D, Raspollini MR, Planchamp F, Centeno C, Chargari C, Felix A, et al. ESGO/ESTRO/ESP Guidelines for the Management of Patients with Cervical Cancer. Int J Gynecol Cancer. 2023;33(5):649–66.
Chino J, Annunziata CM, Beriwal S, Bradfield L, Erickson BA, Fields EC, et al. Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. Pract Radiat Oncol. 2020;10(4):220–34.
American Society of Clinical Oncology. Neoadjuvant Chemotherapy Followed by Surgery Not Superior to Chemoradiation for Locally Advanced Cervical Cancer [Internet]. ASCO. 2023 [cited 2024 Jan 15]. Available from: https://dailynews.ascopubs.org/do/neoadjuvant-chemotherapy-followed-surgery-not-superior-chemoradiation-locally-advanced
Koka K, Verma A, Dwarakanath BS, Papineni RVL. Technological Advancements in External Beam Radiation Therapy (EBRT): An Indispensable Tool for Cancer Treatment. Cancer Manag Res. 2022;14:1421–9.
Kim H, Kim YS, Joo JH, Eom KY, Park W, Kim JH, et al. Tumor boost using external beam radiation in cervical cancer patients unable to receive intracavitary brachytherapy: Outcome from a multicenter retrospective study (Korean Radiation Oncology Group 1419). Int J Gynecol Cancer. 2018;28(2):371–8.
Yu Z, Xu C, Song B, Zhang S, Chen C, Li C, et al. Tissue fibrosis induced by radiotherapy: current understanding of the molecular mechanisms, diagnosis and therapeutic advances. J Transl Med [Internet]. 2023;21(1):1–35. Available from: https://doi.org/10.1186/s12967-023-04554-0
Souza ECA, Santos DZ, Torres JCC, Vale DB, Bragança JF, Teixeira JC. Post-radiotherapy Hysterectomy Does Not Benefit Females with Cervical Adenocarcinoma. Mol Clin Oncol. 2020;13(6):1–6.
Yan W, Qiu S, Si L, Ding Y, Zhang Q, Liu L. Outcome Evaluation of Neoadjuvant Chemotherapy in Patients with Stage IB2 or IIA Cervical Cancer: A Retrospective Comparative Study. Transl Cancer Res. 2020;9(3):1894–900.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Email this article 
